Articles From: Are You A S'more Adorer? to Ares Capital Corporation Announces Public Offering


2013/9/30
Betty Crocker® and Hershey's® Feature A Sweet for Every Style MINNEAPOLIS, Minn.
Sign-up for Are You A S'more Adorer? investment picks
Are you a youth volunteering in your community?
Sign-up for Are you a youth volunteering in your community? Enter the Scotiabank Bright Future Awards now for a chance to win prizes for you and your charity! investment picks
2014/2/6
Are you getting the most out of your RRSP savings?
Sign-up for Are you getting the most out of your RRSP savings? Five important tips from CIBC investment picks
2013/9/24
The search is on for the toughest winter workers in the 3 rd annual Cintas & Carhartt Cold Crew Contest.
Sign-up for Are You North America’s Next Cold Crew Champion? Show us how you ‘Outwork Them AllTM’ investment picks
2012/11/06
What you can do before (and after) a crisis to protect yourself.
Sign-up for Are You Prepared for the Next Disaster? investment picks
2013/10/24
Wall Street and Main Street Don't Agree on What Stocks are Hot, According to Abel/Noser's Liquidity Analysis NEW YORK , Oct.
Sign-up for Are You Trading the Hype? investment picks
2011/03/14
Despite declining portfolio values and incomes, the tax marches onward.
Sign-up for Are You Vulnerable to the Alternative Minimum Tax? investment picks
2013/10/17
SCOTTSDALE, Ariz.
Sign-up for Arem Pacific Corporation Signs Definitive Agreement to Develop Lakeside Resort in China investment picks
-- Collaboration to Focus on Global Commercialization and Development for Weight Management and Potential New Indications --
Sign-up for Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide investment picks
2014/2/12
-- Eisai's Filing for Approval of BELVIQ as a Treatment for Chronic Weight Management Triggers $500,000 Milestone Payment to Arena --
Sign-up for Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil investment picks
-- Preparation for APD811 Phase 2 Clinical Trial Now Underway --
Sign-up for Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension investment picks
2014/2/27
- Conference Call and Webcast Scheduled for Today at 5:00 p.m. Eastern Time - SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results investment picks
-- Second Quarter Highlights Include US launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management --
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results investment picks
2013/11/7
-- Arena and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide -- --
Sign-up for Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results investment picks
2013/9/16
SAN DIEGO , Sept.
Sign-up for Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase investment picks
2014/2/10
-- BELVIQ Now Covered by CVS Caremark --
Sign-up for Arena Pharmaceuticals Reports Coverage for BELVIQ® (lorcaserin HCl) CIV Now Greater Than 50% of Insured Commercial Lives investment picks
2014/4/14
SAN DIEGO , April 14, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management.
Sign-up for Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management investment picks
Expansion to Approximately 400 Sales Specialists Follows Increased Coverage of BELVIQ by Health Plans and Pharmacy Benefit Managers SAN DIEGO , Oct.
Sign-up for Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December investment picks
2013/11/27
SAN DIEGO , Nov.
Sign-up for Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference investment picks
2013/9/6
SAN DIEGO , Sept.
Sign-up for Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference investment picks
2014/2/5
SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences investment picks
2014/2/20
SAN DIEGO , Feb.
Sign-up for Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 investment picks
2013/12/20
Ares Capital Corporation (NASDAQ: ARCC) announced today that it has acquired a diversified middle-market corporate loan portfolio managed by a global banking institution for approximately $319 million.
Sign-up for Ares Capital Corporation Acquires Diversified Middle Market Loan Portfolio For $319 Million investment picks
Ares Capital Corporation (Nasdaq:ARCC) announced that it plans to make a public offering of 11,000,000 shares of its common stock.
Sign-up for Ares Capital Corporation Announces Public Offering investment picks
2013/12/9
Ares Capital Corporation (Nasdaq: ARCC) announced that it plans to make a public offering of 14,300,000 shares of its common stock.
Sign-up for Ares Capital Corporation Announces Public Offering investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Are You A S'more Adorer? to Ares Capital Corporation Announces Public Offering
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity